Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Dent Res ; 86(5): 451-6, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17452567

RESUMO

Ozone has been proposed as an alternative oral antiseptic in dentistry, due to its antimicrobial power reported for gaseous and aqueous forms, the latter showing a high biocompatibility with mammalian cells. New therapeutic strategies for the treatment of periodontal disease and apical periodontitis should consider not only antibacterial effects, but also their influence on the host immune response. Therefore, our aim was to investigate the effect of aqueous ozone on the NF-kappaB system, a paradigm for inflammation-associated signaling/transcription. We showed that NF-kappaB activity in oral cells stimulated with TNF, and in periodontal ligament tissue from root surfaces of periodontally damaged teeth, was inhibited following incubation with ozonized medium. Under this treatment, IkappaBalpha proteolysis, cytokine expression, and kappaB-dependent transcription were prevented. Specific ozonized amino acids were shown to represent major inhibitory components of ozonized medium. In summary, our study establishes a condition under which aqueous ozone exerts inhibitory effects on the NF-kappaB system, suggesting that it has an anti-inflammatory capacity.


Assuntos
NF-kappa B/antagonistas & inibidores , Oxidantes Fotoquímicos/farmacologia , Ozônio/farmacologia , Ativação Transcricional/efeitos dos fármacos , Aminoácidos/farmacologia , Células Cultivadas , Meios de Cultivo Condicionados/farmacologia , Citocinas/antagonistas & inibidores , Células Epiteliais , Fibroblastos , Células HeLa , Humanos , Proteínas I-kappa B/antagonistas & inibidores , Ligamento Periodontal/citologia , Periodontite/metabolismo , Transdução de Sinais/efeitos dos fármacos , Fator de Necrose Tumoral alfa/fisiologia
2.
J Dent Res ; 84(12): 1144-8, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16304444

RESUMO

Pulpotomy is the accepted therapy for the management of cariously exposed pulps in symptom-free primary molars; however, evidence is lacking about the most appropriate technique. The aim of this study was to compare the relative effectiveness of the Er:YAG laser, calcium hydroxide, and ferric sulfate techniques with that of dilute formocresol in retaining such molars symptom-free. Two hundred primary molars in 107 healthy children were included and randomly allocated to one of the techniques. The treated teeth were blindly re-evaluated after 6, 12, 18, and 24 months. Descriptive data analysis and logistic regression analysis, accounting for each patient's effect by a generalized estimating equation (GEE), were used. After 24 months, the following total and clinical success rates were determined (%): formocresol 85 (96), laser 78 (93), calcium hydroxide 53 (87), and ferric sulfate 86 (100). Only calcium hydroxide performed significantly worse than formocresol (p = 0.001, odds ratio = 5.6, 95% confidence interval 2.0-15.5). In conclusion, calcium hydroxide is less appropriate for pulpotomies than is formocresol.


Assuntos
Pulpotomia/métodos , Hidróxido de Cálcio/uso terapêutico , Criança , Pré-Escolar , Coroas , Capeamento da Polpa Dentária , Exposição da Polpa Dentária/terapia , Restauração Dentária Permanente , Feminino , Compostos Férricos/uso terapêutico , Seguimentos , Formocresóis/uso terapêutico , Cimentos de Ionômeros de Vidro , Hemostáticos/uso terapêutico , Humanos , Terapia a Laser , Masculino , Método Simples-Cego , Dente Decíduo/patologia , Resultado do Tratamento , Cimento de Óxido de Zinco e Eugenol
3.
Clin Exp Immunol ; 142(1): 188-92, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16178875

RESUMO

Interleukin (IL)-16 is involved in the regulation of the expression of several proinflammatory cytokines, i.e. tumour necrosis factor (TNF)alpha and interleukin (IL)-1beta. The present study aimed to determine the prevalence of the -295 promoter polymorphism of the interleukin (IL)-16 gene in periodontal disease. A total of 123 patients with periodontal disease and 122 healthy controls were genotyped for the -295 IL-16 promoter polymorphism. Genotyping has been performed by PCR and restriction fragment length polymorphism (RFLP) analysis. The frequencies of alleles and genotypes as well of haplotypes within both study groups were compared using the Pearson chi(2) test at a level of significance of 5% (P < 0.05). The distribution of genotypes for the -295 IL-16 gene polymorphism showed no significant difference between periodontitis patients and healthy control subjects (P = 0.886). Also stratification analysis according to the disease severity revealed no significant difference regarding the genotype distribution among both study groups. Herein the IL-16 -295 gene polymorphism was not associated with chronic periodontitis.


Assuntos
Interleucina-16/genética , Periodontite/genética , Polimorfismo Genético/genética , Adulto , Idoso , Doença Crônica , Feminino , Frequência do Gene/genética , Genótipo , Haplótipos/genética , Humanos , Imunidade Inata/genética , Imunidade Inata/imunologia , Interleucina-16/imunologia , Masculino , Pessoa de Meia-Idade , Periodontite/imunologia , Polimorfismo Genético/imunologia , Polimorfismo de Fragmento de Restrição , Regiões Promotoras Genéticas/genética , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA